The Effects of Iron Treatment on Malaria and Measles Vaccine Response in Kenyan Infants With Iron Deficiency

NANot yet recruitingINTERVENTIONAL
Enrollment

324

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

December 31, 2027

Conditions
Iron Deficiencies
Interventions
DIETARY_SUPPLEMENT

Iron syrup

Iron syrup administered daily from 6 to 10 months of age.

DIETARY_SUPPLEMENT

Multivitamin syrup

Multivitamin syrup administered daily from 6 to 10 months of age.

BIOLOGICAL

R21-Matrix/M Vaccine (malaria vaccine)

R21-Matrix/M vaccine administered in 3 doses at 7, 8 and 9 months of age.

BIOLOGICAL

Measles-Rubella vaccine

Measles-Rubella vaccine administered at 9 months of age.

All Listed Sponsors
collaborator

Jomo Kenyatta University of Agriculture and Technology

OTHER

collaborator

University of Oxford - Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences

UNKNOWN

collaborator

Faculty of Medical Sciences, Radboud University of Medical Center

UNKNOWN

collaborator

National Institute for Public Health and the Environment (RIVM)

OTHER_GOV

lead

Swiss Federal Institute of Technology

OTHER